CRATER numbers increase in patients responding to ICB treatment, whereas patients with progressive disease (PD) post treatment demonstrated disseminated CD8+ T cell infiltration throughout the tumor parenchyma and few CRATERs. This evidence concerns the gene CD8A and neoplasm.